(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-bromopent-4-enoic acid, 95+%, 100mg

6-Chloro-3-indoxyl-β-D-glucuronic acid cyclohexylammonium salt, 100 mg, >=98%

(5-Bromopyrimidin-2-yl)acetic acid ethyl ester, 98.0%, 100g

(2R,3S,4R)-2-(Hydroxymethyl)-3,4-dihydro-2H-pyran-3,4-diol, 95.0%, 1g

trans-3-Aminocyclopentanol hydrochloride, 95.0%, 1g

RUCAPARIB, 98%, 5g

(11bS)-N,N,2,6-Tetramethyl-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 97%, 100mg

(3S,4S)-3-Methyltetrahydropyran-4-amine hydrochloride, 98%, 250mg

4-(Di-p-tolylamino)benzaldehyde>98.0%(HPLC)5g

(5-(6-Chloropyridazin-3-yl)-1,3,4-oxadiazol-2-yl)methanol, 98%, 100mg

Ethyl 2-(2-chloroethoxy)acetate, 95.0%, 25g

Benzo[d]isoxazol-5-amine, 95.0%, 10g

METHYL 5-(CHLOROSULFONYL)-1-NAPHTHOATE, 95%, 500mg